PREDICtors for Quality of Life After Sigmoidectomy for DIVerticular Disease
NCT ID: NCT03527706
Last Updated: 2023-09-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
165 participants
OBSERVATIONAL
2017-11-28
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bowel Function/QoL After Elective Sigmoidectomy vs. Conservative Management for Recurrent Uncomplicated Diverticulitis
NCT03994978
Quality of Life (QOL) After Elective Sigmoidectomy for Diverticular Diseases (DIVERTI)
NCT04730765
Quality of Life and Surgery in Diverticular Disease
NCT05393609
Comparison of Quality of Life and Functionnal Resultats After Sigmodectomy Between Diverticulitis and Cancer
NCT04729283
PREDICS Study: PCT Reveals Early Dehiscence in Colorectal Surgery
NCT01817647
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \>18 years
* ASA 1-3
* informed consent
Exclusion Criteria
* ASA 4
* acute diverticulitis with free perforation
* acute or forgoing diverticular bleeding
* colorectal malignancies (current or foregoing)
* immunosuppression (corticoids \> 20 mg prednisolon/d, status post transplant)
* advanced malignancy with systemic metastases
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Städtisches Klinikum München GmbH
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Maximilian Sohn
Dr. med., Attending
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maximilian Sohn, Dr. med.
Role: STUDY_DIRECTOR
Städtisches Klinikum München GmbH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Klinik für Allgemein- Viszeral-, Endokrine- und Minimalinvasive Chirurgie, Klinikum Bogenhausen, Städtisches Klinikum München GmbH
Munich, Bavaria, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Sohn M, Agha A, Iesalnieks I, Bremer S, Trum S, Di Cerbo F, Nerlich A, Lotz N, Klieser E, Hochrein A, Schredl P, Kalcheva D, Emmanuel K, Presl J. PREDICtors for health-related quality of life after elective sigmoidectomy for DIVerticular disease: the PREDIC-DIV study protocol of a prospective multicentric transnational observational study. BMJ Open. 2020 Mar 24;10(3):e034385. doi: 10.1136/bmjopen-2019-034385.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PREDIC-DIV 1.0
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.